Bridgefront Capital LLC Makes New $355,000 Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

Bridgefront Capital LLC acquired a new position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,777 shares of the company's stock, valued at approximately $355,000.

Several other institutional investors and hedge funds have also recently modified their holdings of SGRY. Wells Fargo & Company MN boosted its stake in Surgery Partners by 1.4% in the 4th quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock worth $1,205,000 after purchasing an additional 783 shares during the period. MeadowBrook Investment Advisors LLC lifted its position in shares of Surgery Partners by 16.6% in the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after buying an additional 1,460 shares in the last quarter. KBC Group NV boosted its position in shares of Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after acquiring an additional 1,577 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Surgery Partners by 1.3% in the 4th quarter. Rhumbline Advisers now owns 121,852 shares of the company's stock worth $2,580,000 after buying an additional 1,588 shares in the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Surgery Partners by 6.1% in the 4th quarter. MetLife Investment Management LLC now owns 47,027 shares of the company's stock worth $996,000 after buying an additional 2,684 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Macquarie dropped their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Benchmark reissued a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Monday, April 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $34.75.

Surgery Partners Trading Up 3.3%

Surgery Partners stock traded up $0.73 during trading hours on Monday, hitting $22.89. The company had a trading volume of 666,841 shares, compared to its average volume of 1,085,873. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market cap of $2.93 billion, a P/E ratio of -47.64, a P/E/G ratio of 19.21 and a beta of 1.96. The company has a 50-day moving average price of $22.61 and a two-hundred day moving average price of $23.37. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $864.40 million during the quarter, compared to analyst estimates of $828.09 million. On average, sell-side analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Insider Transactions at Surgery Partners

In related news, CFO David T. Doherty sold 6,733 shares of the business's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the completion of the transaction, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marissa Brittenham sold 3,156 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This represents a 4.74% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.